SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (7814)2/6/2001 11:10:43 PM
From: Jibacoa  Read Replies (1) | Respond to of 13094
 
JIM:

BIORY: Has closed the Jan.30 up-gap. Now ready to roll again ?

This is the news that caused the up-gap on Jan.30:

Biora AB announced that, the Federal Drug Administration has given the Company approval to sell its newest product for treatment of periodontitis, Emdogain Gel, in the U.S. The Company's U.S. subsidiary will immediately begin selling the product to periodontists in the U.S. Emdogain Gel has recently received approval in Brazil and Mexico as well.

RAGL

Bernard



To: James Strauss who wrote (7814)2/7/2001 11:56:06 AM
From: Jibacoa  Read Replies (1) | Respond to of 13094
 
JIM:

INSP: It seems it is trying to make a bottom at yesterday's low,around the 3.56 level.

It has a good amount of overhead resistance at the 5 1/16 to 6.56 level before it could test the Jan.Hs, and of course a long way to go to last year's March H of 138.50 <g>

The DOW trying again for the overhead resistance and the NASDAQ headed to re-test support levels<G>

RAGL

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News